Anticancer Therapies – Multimedia

Speaking at The Landscape of Cancer Research 2022 online symposium, keynote speaker Grant McFadden of the University of Arizona delivered his talk on recent advances and challenges in oncolytic virotherapy.

Speaking at The Landscape of Cancer Research 2022 online symposium, Eric Kmiec of the Gene Editing Institute, ChristianaCare, delivered his talk on advances in CRISPR gene editing.

Speaking at The Landscape of Cancer Research 2022 online symposium, Sofia Lourenco of Cancer Research Horizons delivered her talk on the challenges facing the future of cancer immunotherapies.

Speaking at The Landscape of Cancer Research 2022 online symposium, James Moon from the University of Michigan delivered his talk on next-generation STING agonists for immunotherapy against advanced cancer.

A vaccine which targets an aggressive form of breast cancer is moving forward to a second trial involving patients fighting cancer.

Speaking at Drug Discovery & Development online symposium 2021, Pei Liu from GenScript, presented her talk on monoclonal antibodies.

It has proven difficult to accurately identify the biological targets of cancer, which are necessary for the development of successful therapeutics including novel immunotherapies, such as those based on chimeric antigen receptor (CAR) T cells.

This listicle highlights five commonly used cell viability assays and their benefits and limitations in immunotherapy potency testing.

Speaking at The Landscape of Cancer Research 2021, Prof. Emanuel Petricoin from The George Mason University, presented his talk on pharmacoproteomics.

Speaking at The Landscape of Cancer Research 2021 online symposium, Tianzi Li delivered her talk on the discovery of novel targets and the use of antibodies in cancer therapy.